Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: GLRX5-associated [Fe-S] cluster biogenesis disorder: further characterisation of the neurological phenotype and long-term outcome

Fig. 1

Box plot indicating median and interquartile ranges in box, (and full range with lines) of plasma glycine and leucine levels for the span of treatment, after diagnosis of variant NKH had been established in four patients. P1—Monitored from 4 to 17 years (18 tests). P2—Monitored from 8.5 to 19 years (41 tests). P3—Monitored from 33 to 57 years (30 tests). P4—Monitored from 22 to 46 years (45 tests)

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172